<DOC>
	<DOC>NCT00099879</DOC>
	<brief_summary>The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.</brief_summary>
	<brief_title>Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Advanced or metastatic pretreated NSCLC Measurable disease Adequate hematologic, hepatic and renal functions ECOG Performance Status of 02 Inability to swallow capsules Recent significant cardiovascular disease Woman who are pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>